The global EXTL1 Antibody market size in 2023 is xx million US dollars, and it is expected to be xx million US dollars by 2030, with a compound annual growth rate of xx% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the EXTL1 Antibody market include Novus Biologicals, Abbexa, Origene, Lifespan Biosciences, and Boster Bio. The share of the top 3 players in the EXTL1 Antibody market is xx%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for xx%, Europe accounted for xx% of EXTL1 Antibody market, and Asia Pacific accounted for xx%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Above 90% accounted for xx% of EXTL1 Antibody market in 2023. Above 95% share of xx%.
Biopharmaceutical Companies accounted for xx% of the EXTL1 Antibody market in 2023. Hospitals accounts for xx%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global EXTL1 Antibody Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of EXTL1 Antibody market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the EXTL1 Antibody industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and the latest developments.
Chapters 4-5: Segmented the global EXTL1 Antibody market by type, and application. Analyze the revenue, sales and price of market segments from different perspectives.
Chapters 6-7: Provide global EXTL1 Antibody market production status and consumption status by region.
Chapters 8-12: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa EXTL1 Antibody market country segmentation data.
Chapter 13: Analyzes the EXTL1 Antibody industry chain, including raw material analysis, sales and marketing, distributors and major downstream buyers.
Chapter 14: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes market technology analysis.
Chapter 15: The main points and conclusions of the report.
Chapter 16: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
Novus Biologicals
Abbexa
Origene
Lifespan Biosciences
Boster Bio
Biobyt
Atlas Antibodies
Bioss Antibodies
Aviva Systems Biology
Types list
Above 90%
Above 95%
Above 107%
Others
Application list
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
Table of Content
1 Study Coverage
1.1 EXTL1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global EXTL1 Antibody Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global EXTL1 Antibody Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Study Objectives
1.5 Years Considered
1.6 Currency Exchange Rate
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global EXTL1 Antibody Sales by Players
2.1.1 Global EXTL1 Antibody Sales by Players (2019-2024)
2.1.2 Global EXTL1 Antibody Sales Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Largest Players of EXTL1 Antibody in 2024
2.2 Global EXTL1 Antibody Revenue by Players
2.2.1 Global EXTL1 Antibody Revenue by Players (2019-2024)
2.2.2 Global EXTL1 Antibody Revenue Market Share by Players (2019-2024)
2.2.3 Global Top 5 and Top 10 Companies by EXTL1 Antibody Revenue in 2024
2.3 Global EXTL1 Antibody Sales Price by Players
2.4 Analysis of Competitive Landscape
2.4.1 Players Market Concentration Ratio (CR5)
2.4.2 Global EXTL1 Antibody Players Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Novus Biologicals
3.1.1 Novus Biologicals Information
3.1.2 Novus Biologicals Overview
3.1.3 Novus Biologicals EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.1.4 Novus Biologicals Related Developments
3.2 Abbexa
3.2.1 Abbexa Information
3.2.2 Abbexa Overview
3.2.3 Abbexa EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.2.4 Abbexa Related Developments
3.3 Origene
3.3.1 Origene Information
3.3.2 Origene Overview
3.3.3 Origene EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.3.4 Origene Related Developments
3.4 Lifespan Biosciences
3.4.1 Lifespan Biosciences Information
3.4.2 Lifespan Biosciences Overview
3.4.3 Lifespan Biosciences EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.4.4 Lifespan Biosciences Related Developments
3.5 Boster Bio
3.5.1 Boster Bio Information
3.5.2 Boster Bio Overview
3.5.3 Boster Bio EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.5.4 Boster Bio Related Developments
3.6 Biobyt
3.6.1 Biobyt Information
3.6.2 Biobyt Overview
3.6.3 Biobyt EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.6.4 Biobyt Related Developments
3.7 Atlas Antibodies
3.7.1 Atlas Antibodies Information
3.7.2 Atlas Antibodies Overview
3.7.3 Atlas Antibodies EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.7.4 Atlas Antibodies Related Developments
3.8 Bioss Antibodies
3.8.1 Bioss Antibodies Information
3.8.2 Bioss Antibodies Overview
3.8.3 Bioss Antibodies EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.8.4 Bioss Antibodies Related Developments
3.9 Aviva Systems Biology
3.9.1 Aviva Systems Biology Information
3.9.2 Aviva Systems Biology Overview
3.9.3 Aviva Systems Biology EXTL1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
3.9.4 Aviva Systems Biology Related Developments
4 Market Size by Type
4.1 Global EXTL1 Antibody Sales by Type
4.1.1 Global EXTL1 Antibody Sales by Type (2019-2024)
4.1.2 Global EXTL1 Antibody Forecasted Sales by Type (2024-2030)
4.2 Global EXTL1 Antibody Revenue by Type
4.2.1 Global EXTL1 Antibody Revenue by Type (2019-2024)
4.2.2 Global EXTL1 Antibody Forecasted Revenue by Type (2024-2030)
4.3 Global EXTL1 Antibody Price by Type
4.3.1 Global EXTL1 Antibody Price by Type (2019-2024)
4.3.2 Global EXTL1 Antibody Price Forecast by Type (2024-2030)
5 Market Size by Application
5.1 Global EXTL1 Antibody Sales by Application
5.1.1 Global EXTL1 Antibody Sales by Application (2019-2024)
5.1.2 Global EXTL1 Antibody Forecasted Sales by Application (2024-2030)
5.2 Global EXTL1 Antibody Revenue by Application
5.2.1 Global EXTL1 Antibody Revenue by Application (2019-2024)
5.2.2 Global EXTL1 Antibody Forecasted Revenue by Application (2024-2030)
5.3 Global EXTL1 Antibody Price by Application
5.3.1 Global EXTL1 Antibody Price by Application (2019-2024)
5.3.2 Global EXTL1 Antibody Price Forecast by Application (2024-2030)
6 Global EXTL1 Antibody Production
6.1 Global EXTL1 Antibody Production (2019-2030)
6.2 Global EXTL1 Antibody Production by Region: 2019 VS 2024 VS 2030
6.3 Global EXTL1 Antibody Production by Region
6.3.1 Global EXTL1 Antibody Historic Production by Region (2019-2024)
6.3.2 Global EXTL1 Antibody Forecasted Production by Region (2024-2030)
6.4 North America
6.5 Europe
6.6 China
6.7 Japan
7 Global EXTL1 Antibody Market Insights Estimates and Forecasts
7.1 Global EXTL1 Antibody Sales Estimates and Forecasts 2019-2030
7.2 Global EXTL1 Antibody Revenue Estimates and Forecasts 2019-2030
7.3 Global EXTL1 Antibody Sales by Region: 2019 VS 2024 VS 2030
7.4 Global EXTL1 Antibody Sales by Region
7.4.1 Global EXTL1 Antibody Sales by Region (2019-2024)
7.4.2 Global EXTL1 Antibody Sales by Region (2024-2030)
7.5 Global EXTL1 Antibody Revenue by Region
7.5.1 Global EXTL1 Antibody Revenue by Region (2019-2024)
7.5.2 Global EXTL1 Antibody Revenue by Region (2024-2030)
7.6 North America
7.7 Europe
7.8 Asia-Pacific
7.9 Latin America
7.10 Middle East & Africa
8 North America
8.1 North America EXTL1 Antibody Market Size by Country
8.1.1 North America EXTL1 Antibody Sales by Country (2019-2030)
8.1.2 North America EXTL1 Antibody Revenue by Country (2019-2030)
8.1.3 U.S.
8.1.4 Canada
9 Europe
9.1 Europe EXTL1 Antibody Market Size by Country
9.1.1 Europe EXTL1 Antibody Sales by Country (2019-2030)
9.1.2 Europe EXTL1 Antibody Revenue by Country (2019-2030)
9.1.3 Germany
9.1.4 France
9.1.5 U.K.
9.1.6 Italy
9.1.7 Russia
10 Asia Pacific
10.1 Asia Pacific EXTL1 Antibody Market Size by Region
10.1.1 Asia Pacific EXTL1 Antibody Sales by Region (2019-2030)
10.1.2 Asia Pacific EXTL1 Antibody Revenue by Region (2019-2030)
10.1.3 China
10.1.4 Japan
10.1.5 South Korea
10.1.6 India
10.1.7 Southeast Asia
10.1.8 Australia
11 Latin America
11.1 Latin America EXTL1 Antibody Market Size by Country
11.1.1 Latin America EXTL1 Antibody Sales by Country (2019-2030)
11.1.2 Latin America EXTL1 Antibody Revenue by Country (2019-2030)
11.1.3 Mexico
11.1.4 Brazil
12 Middle East and Africa
12.1 Middle East and Africa EXTL1 Antibody Market Size by Country
12.1.1 Middle East and Africa EXTL1 Antibody Sales by Country (2019-2030)
12.1.2 Middle East and Africa EXTL1 Antibody Revenue by Country (2019-2030)
12.1.3 Turkey
12.1.4 Saudi Arabia
12.1.5 U.A.E
13 Value Chain and Channels Analysis
13.1 EXTL1 Antibody Value Chain Analysis
13.2 EXTL1 Antibody Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 EXTL1 Antibody Production Mode & Process
13.4 EXTL1 Antibody Sales and Marketing
13.4.1 EXTL1 Antibody Sales Channels
13.4.2 EXTL1 Antibody Distributors
13.5 EXTL1 Antibody Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 EXTL1 Antibody Industry Trends
14.2 EXTL1 Antibody Market Drivers
14.3 EXTL1 Antibody Market Challenges
14.4 EXTL1 Antibody Market Restraints
14.5 EXTL1 Antibody Market Technology Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer
List of Tables and Figures
Figure EXTL1 Antibody Picture
Table Product Definition of EXTL1 Antibody
Table Global EXTL1 Antibody Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global EXTL1 Antibody Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global EXTL1 Antibody Sales by Players (2019-2024)
Table Global EXTL1 Antibody Sales Market Share by Players (2019-2024)
Figure Top 5 Largest Players of EXTL1 Antibody in 2024
Figure Top 10 Largest Players of EXTL1 Antibody in 2024
Table Global EXTL1 Antibody Revenue by Players (2019-2024)
Table Global EXTL1 Antibody Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of EXTL1 Antibody in 2024
Figure Top 10 Largest Players of EXTL1 Antibody in 2024
Table Global EXTL1 Antibody Sales Price by Players
Table Players Market Concentration Ratio (CR5)
Table Global EXTL1 Antibody Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Novus Biologicals Overview
Table Novus Biologicals Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Novus Biologicals Related Developments
Table Company Profiles
Table Abbexa Overview
Table Abbexa Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Abbexa Related Developments
Table Company Profiles
Table Origene Overview
Table Origene Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Origene Related Developments
Table Company Profiles
Table Lifespan Biosciences Overview
Table Lifespan Biosciences Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Lifespan Biosciences Related Developments
Table Company Profiles
Table Boster Bio Overview
Table Boster Bio Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Boster Bio Related Developments
Table Company Profiles
Table Biobyt Overview
Table Biobyt Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Biobyt Related Developments
Table Company Profiles
Table Atlas Antibodies Overview
Table Atlas Antibodies Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Atlas Antibodies Related Developments
Table Company Profiles
Table Bioss Antibodies Overview
Table Bioss Antibodies Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Bioss Antibodies Related Developments
Table Company Profiles
Table Aviva Systems Biology Overview
Table Aviva Systems Biology Sales, Price, Revenue, Gross, Gross Margin 2019-2024
Table Aviva Systems Biology Related Developments
Table Global EXTL1 Antibody Sales by Type (2019-2024)
Table Global EXTL1 Antibody Sales Share by Type (2019-2024)
Table Global EXTL1 Antibody Forecasted Sales by Type (2024-2030)
Table Global EXTL1 Antibody Forecasted Sales Share by Type (2024-2030)
Table Global EXTL1 Antibody Revenue by Type (2019-2024)
Table Global EXTL1 Antibody Revenue Share by Type (2019-2024)
Table Global EXTL1 Antibody Forecasted Revenue by Type (2024-2030)
Table Global EXTL1 Antibody Forecasted Revenue Share by Type (2024-2030)
Table Global EXTL1 Antibody Price by Type (2019-2024)
Table Global EXTL1 Antibody Price Forecast by Type (2024-2030)
Table Global EXTL1 Antibody Sales by Application (2019-2024)
Table Global EXTL1 Antibody Sales Share by Application (2019-2024)
Table Global EXTL1 Antibody Forecasted Sales by Application (2024-2030)
Table Global EXTL1 Antibody Forecasted Sales Share by Application (2024-2030)
Table Global EXTL1 Antibody Revenue by Application (2019-2024)
Table Global EXTL1 Antibody Revenue Share by Application (2019-2024)
Table Global EXTL1 Antibody Forecasted Revenue by Application (2024-2030)
Table Global EXTL1 Antibody Forecasted Revenue Share by Application (2024-2030)
Table Global EXTL1 Antibody Price by Application (2019-2024)
Table Global EXTL1 Antibody Price Forecast by Application (2024-2030)
Figure Global EXTL1 Antibody Production (2019-2030)
Table Global EXTL1 Antibody Production by Region: 2019 VS 2024 VS 2030
Table Global EXTL1 Antibody Historic Production by Region (2019-2024)
Table Global EXTL1 Antibody Historic Production Share by Region (2019-2024)
Table Global EXTL1 Antibody Forecasted Production by Region (2024-2030)
Table Global EXTL1 Antibody Forecasted Production Share by Region (2024-2030)
Figure North America EXTL1 Antibody Production (2019-2030)
Figure Europe EXTL1 Antibody Production (2019-2030)
Figure China EXTL1 Antibody Production (2019-2030)
Figure Japan EXTL1 Antibody Production (2019-2030)
Figure Global EXTL1 Antibody Sales Estimates and Forecasts 2019-2030
Figure Global EXTL1 Antibody Revenue Estimates and Forecasts 2019-2030
Table Global EXTL1 Antibody Sales by Region: 2019 VS 2024 VS 2030
Table Global EXTL1 Antibody Sales by Region (2019-2024)
Table Global EXTL1 Antibody Sales Share by Region (2019-2024)
Table Global EXTL1 Antibody Sales by Region (2024-2030)
Table Global EXTL1 Antibody Sales Share by Region (2024-2030)
Table Global EXTL1 Antibody Revenue by Region (2019-2024)
Table Global EXTL1 Antibody Revenue Share by Region (2019-2024)
Table Global EXTL1 Antibody Revenue by Region (2024-2030)
Table Global EXTL1 Antibody Revenue Share by Region (2024-2030)
Figure North America EXTL1 Antibody Sales (2019-2030)
Figure North America EXTL1 Antibody Revenue (2019-2030)
Figure Europe EXTL1 Antibody Sales (2019-2030)
Figure Europe EXTL1 Antibody Revenue (2019-2030)
Figure Asia-Pacific EXTL1 Antibody Sales (2019-2030)
Figure Asia-Pacific EXTL1 Antibody Revenue (2019-2030)
Figure Latin America EXTL1 Antibody Sales (2019-2030)
Figure Latin America EXTL1 Antibody Revenue (2019-2030)
Figure Middle East & Africa EXTL1 Antibody Sales (2019-2030)
Figure Middle East & Africa EXTL1 Antibody Revenue (2019-2030)
Table North America EXTL1 Antibody Sales by Country (2019-2030)
Table North America EXTL1 Antibody Sales Share by Country (2019-2030)
Table North America EXTL1 Antibody Revenue by Country (2019-2030)
Table North America EXTL1 Antibody Revenue Share by Country (2019-2030)
Figure United States EXTL1 Antibody Sales Market Size (2019-2030)
Figure United States EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Canada EXTL1 Antibody Sales Market Size (2019-2030)
Figure Canada EXTL1 Antibody Revenue Market Size (2019-2030)
Table Europe EXTL1 Antibody Sales by Country (2019-2030)
Table Europe EXTL1 Antibody Sales Share by Country (2019-2030)
Table Europe EXTL1 Antibody Revenue by Country (2019-2030)
Table Europe EXTL1 Antibody Revenue Share by Country (2019-2030)
Figure Germany EXTL1 Antibody Sales Market Size (2019-2030)
Figure Germany EXTL1 Antibody Revenue Market Size (2019-2030)
Figure France EXTL1 Antibody Sales Market Size (2019-2030)
Figure France EXTL1 Antibody Revenue Market Size (2019-2030)
Figure U.K. EXTL1 Antibody Sales Market Size (2019-2030)
Figure U.K. EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Italy EXTL1 Antibody Sales Market Size (2019-2030)
Figure Italy EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Russia EXTL1 Antibody Sales Market Size (2019-2030)
Figure Russia EXTL1 Antibody Revenue Market Size (2019-2030)
Table Asia Pacific EXTL1 Antibody Sales by Region (2019-2030)
Table Asia Pacific EXTL1 Antibody Sales Share by Region (2019-2030)
Table Asia Pacific EXTL1 Antibody Revenue by Region (2019-2030)
Table Asia Pacific EXTL1 Antibody Revenue Share by Region (2019-2030)
Figure China EXTL1 Antibody Sales Market Size (2019-2030)
Figure China EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Japan EXTL1 Antibody Sales Market Size (2019-2030)
Figure Japan EXTL1 Antibody Revenue Market Size (2019-2030)
Figure South Korea EXTL1 Antibody Sales Market Size (2019-2030)
Figure South Korea EXTL1 Antibody Revenue Market Size (2019-2030)
Figure India EXTL1 Antibody Sales Market Size (2019-2030)
Figure India EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Southeast Asia EXTL1 Antibody Sales Market Size (2019-2030)
Figure Southeast Asia EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Australia EXTL1 Antibody Sales Market Size (2019-2030)
Figure Australia EXTL1 Antibody Revenue Market Size (2019-2030)
Table Latin America EXTL1 Antibody Sales by Country (2019-2030)
Table Latin America EXTL1 Antibody Sales Share by Country (2019-2030)
Table Latin America EXTL1 Antibody Revenue by Country (2019-2030)
Table Latin America EXTL1 Antibody Revenue Share by Country (2019-2030)
Figure Mexico EXTL1 Antibody Sales Market Size (2019-2030)
Figure Mexico EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Brazil EXTL1 Antibody Sales Market Size (2019-2030)
Figure Brazil EXTL1 Antibody Revenue Market Size (2019-2030)
Table Middle East and Africa EXTL1 Antibody Sales by Country (2019-2030)
Table Middle East and Africa EXTL1 Antibody Sales Share by Country (2019-2030)
Table Middle East and Africa EXTL1 Antibody Revenue by Country (2019-2030)
Table Middle East and Africa EXTL1 Antibody Revenue Share by Country (2019-2030)
Figure Turkey EXTL1 Antibody Sales Market Size (2019-2030)
Figure Turkey EXTL1 Antibody Revenue Market Size (2019-2030)
Figure Saudi Arabia EXTL1 Antibody Sales Market Size (2019-2030)
Figure Saudi Arabia EXTL1 Antibody Revenue Market Size (2019-2030)
Figure U.A.E EXTL1 Antibody Sales Market Size (2019-2030)
Figure U.A.E EXTL1 Antibody Revenue Market Size (2019-2030)
Table Raw Material
Table Raw Materials Key Suppliers
Figure Sales Channels
Table Major Distributors of EXTL1 Antibody with Contact Information
Table Major Customers of EXTL1 Antibody with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report